In contrast, type 2 DM (T2DM) is characterized by impaired insulin production and/or receptor signaling and magnified by the obesity epidemic and an unhealthy lifestyle, which disturbs insulin signaling via not only the production of unhealthy mediators from adipose tissue but also the exaggerated fueling of glucose-dependent pathways. Here, INS is linked to obesity disorder.